© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) stock declined over -12.18%, trading at $1.93 on OTC, down from the previous close of $2.20. The stock opened at $1.93, fluctuating between $1.93 and $2.20 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 1.93 | 1.93 | 1.93 | 1.93 | 2.96K |
| Aug 19, 2026 | 2.20 | 2.20 | 2.20 | 2.20 | 430 |
| Aug 18, 2026 | 2.12 | 2.12 | 2.12 | 2.12 | 1.68K |
| Aug 10, 2026 | 1.95 | 1.95 | 1.95 | 1.95 | 100 |
| Jul 07, 2026 | 2.15 | 2.20 | 2.15 | 2.20 | 620 |
| Jun 18, 2026 | 2.02 | 2.02 | 2.02 | 2.02 | 7K |
| Jun 11, 2026 | 2.02 | 2.02 | 2.02 | 2.02 | 175 |
| May 22, 2026 | 2.17 | 2.17 | 2.17 | 2.17 | 202 |
| Apr 27, 2026 | 2.60 | 2.60 | 2.60 | 2.60 | 90 |
| Apr 22, 2026 | 2.60 | 2.60 | 2.60 | 2.60 | 150 |
| Mar 27, 2026 | 2.46 | 2.70 | 2.46 | 2.70 | 650 |
| Mar 25, 2026 | 2.71 | 2.71 | 2.71 | 2.71 | 500 |
| Mar 13, 2026 | 2.44 | 2.44 | 2.44 | 2.44 | 200 |
| Mar 03, 2026 | 2.50 | 2.50 | 2.33 | 2.33 | 300 |
| Feb 06, 2026 | 2.61 | 2.61 | 2.61 | 2.61 | 1K |
| Feb 02, 2026 | 2.66 | 2.66 | 2.66 | 2.66 | 2.12K |
| Jan 21, 2026 | 2.86 | 2.86 | 2.86 | 2.86 | 300 |
| Jan 13, 2026 | 2.78 | 2.78 | 2.78 | 2.78 | 900 |
| Jan 02, 2026 | 2.78 | 2.78 | 2.78 | 2.78 | 7K |
| Dec 31, 2025 | 2.50 | 2.50 | 2.50 | 2.50 | 130 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise. The company is actively engaged in the research, development, manufacturing, and sale of pharmaceutical products, serving markets across Mainland China and internationally. Its diverse operations are structured into five main segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Services, Pharmaceutical Distribution and Retail, and Other Business activities. Within its pharmaceutical portfolio, Fosun Pharma focuses on critical therapeutic areas such as oncology, immune system modulation, metabolic disorders, gastrointestinal conditions, and central nervous system ailments. Beyond its drug offerings, the company also provides a range of medical equipment and diagnostic solutions. Furthermore, SFOSF is involved in delivering healthcare services and managing hospitals, alongside its wholesale and retail distribution of medicines.
| Employees | 40603 |
| Beta | 0.44 |
| Sales or Revenue | $41.40B |
| 5Y Sales Change% | 0.563% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |